Novel roles for GAPDH in cell death and carcinogenesis

Cell Death and Differentiation

Volumn 16, Issue 12, 2009, Pages 1573-1581

  Colell, A ^a   Green, D R ^b   Ricci, J E ^c,d,e  

^a INST D INVESTIGACIONS B   (Spain)

^b St Jude Children's Research Institute   (United States)

^c CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

^e UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; COLONY STIMULATING FACTOR 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMATINIB; KONINGIC ACID; PREDNISOLONE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; AUTOPHAGY; CARCINOGENESIS; CELL FATE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CHRONIC MYELOID LEUKEMIA; DISULFIDE BOND; DOWN REGULATION; GLYCOLYSIS; HUMAN; MICROTUBULE ASSEMBLY; MITOCHONDRIAL PERMEABILITY; NITROSYLATION; NONHUMAN; OVARY CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; RNA PROCESSING; SARCOPLASMIC RETICULUM; TUMOR CELL DESTRUCTION; TUMOR GROWTH;

ANIMALS; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; REACTIVE OXYGEN SPECIES;

EID: 70449712602     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.137     Document Type: Review

References (105)

1. Sirover MA. New insights into an old protein: The functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1999; 1432: 159-184.
2. Sirover MA. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 2005; 95: 45-52.
3. Morero RD, Vinals AL, Bloj B, Farias RN. Fusion of phospholipid vesicles induced by muscle glyceraldehyde-3-phosphate dehydrogenase in the absence of calcium. Biochemistry 1985; 24: 1904-1909.
4. Robbins AR, Ward RD, Oliver C. A mutation in glyceraldehyde 3-phosphate dehydrogenase alters endocytosis in CHO cells. J Cell Biol 1995; 130: 1093-1104.
5. Nakagawa T, Hirano Y, Inomata A, Yokota S, Miyachi K, Kaneda M et al Participation of a fusogenic protein, glyceraldehyde-3-phosphate dehydrogenase, in nuclear membrane assembly. J Biol Chem 2003; 278: 20395-20404.
6. Tisdale EJ, Kelly C, Artalejo CR. Glyceraldehyde-3-phosphate dehydrogenase interacts with Rab2 and plays an essential role in endoplasmic reticulum to Golgi transport exclusive of its glycolytic activity. J Biol Chem 2004; 279: 54046-54052.
7. Walsh JL, Keith TJ, Knull HR. Glycolytic enzyme interactions with tubulin and microtubules. Biochim Biophys Acta 1989; 999: 64-70.
8. Huitorel P, Pantaloni D. Bundling of microtubules by glyceraldehyde-3-phosphate dehydrogenase and its modulation by ATP. Eur J Biochem 1985; 150: 265-269.
9. Tisdale EJ, Azizi F, Artalejo CR. Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase C\{iota\} to associat. J Biol Chem 2009; 284: 5876-5884.
10. Singh R, Green MR. Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 1993; 259: 365-368.
11. Nagy E, Henics T, Eckert M, Miseta A, Lightowlers RN, Kellermayer M. Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem Biophys Res Commun 2000; 275: 253-260.
12. Rodriguez-Pascual F, Redondo-Horcajo M, Magan-Marchal N, Lagares D, Martinez-Ruiz A, Kleinert H et al. Glyceraldehyde-3-phosphate dehydrogenase regulates endothelin-1 expression by a novel, redox-sensitive mechanism involving mRNA stability. Mol Cell Biol 2008; 28: 7139-7155.
13. Zhou Y, Yi X, Stoffer JB, Bonafe N, Gilmore-Hebert M, McAlpine J et al. The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol Cancer Res 2008; 6: 1375-1384.
14. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 2003; 114: 255-266.
15. Mitsuzawa H, Kimura M, Kanda E, Ishihama A. Glyceraldehyde-3-phosphate dehydrogenase and actin associate with RNA polymerase II and interact with its Rpb7 subunit. FEBS Lett 2005; 579: 48-52.
16. Meyer-Siegler K, Mauro DJ, Seal G, Wurzer J, deRiel JK, Sirover MA. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci USA 1991; 88: 8460-8464.
17. Krynetski EY, Krynetskaia NF, Gallo AE, Murti KG, Evans WE. A novel protein complex distinct from mismatch repair binds thioguanylated DNA. Mol Pharmacol 2001; 59: 367-374.
18. Sundararaj KP, Wood RE, Ponnusamy S, Salas AM, Szulc Z, Bielawska A et al. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 2004; 279 6152-6162.
19. Meyer-Siegler K, Rahman-Mansur N, Wurzer JC, Sirover MA. Proliferative dependent regulation of the glyceraldehyde-3-phosphate dehydrogenase/ uracil DNA glycosylase gene in human cells. Carcinogenesis 1992; 13: 2127-2132.
20. Mansur NR, Meyer-Siegler K, Wurzer JC, Sirover MA. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res 1993; 21: 993-998.
21. Netzker R, Hermfisse U, Wein KH, Brand K. Expression of glycolytic isozymes in rat thymocytes during cell cycle progression. Biochim Biophys Acta 1994; 1224: 371-376.
22. Graven KK, Yu Q, Pan D, Roncarati JS, Farber HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim Biophys Acta 1999; 1447: 208-218.
23. Alexander-Bridges M, Dugast I, Ercolani L, Kong XF, Giere L, Nasrin N. Multiple insulin-responsive elements regulate transcription of the GAPDH gene. Adv Enzyme Regul 1992; 32: 149-159.
24. Folkman J, Hahnfeldt P, Hlatky L. Cancer: Looking outside the genome. Nat Rev Mol Cell Biol 2000; 1: 76-79.
25. Lartigau E, Le Ridant AM, Lambin P, Weeger P, Martin L, Sigal R et al Oxygenation of head and neck tumors. Cancer 1993; 71: 2319-2325.
26. Lartigau E, Randrianarivelo H, Avril MF, Margulis A, Spatz A, Eschwege F et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res 1997; 7: 400-406.
27. Semenza GL. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000; 88: 1474-1480.
28. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci USA 1994; 91: 6496-6500.
29. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-23763.
30. Graven KK, Troxler RF, Kornfeld H, Panchenko MV, Farber HW. Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J Biol Chem 1994; 269: 24446-24453.
31. Graven KK, Bellur D, Klahn BD, Lowrey SL, Amberger E. HIF-2alpha regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells. Biochim Biophys Acta 2003; 1626: 10-18.
32. Cuervo AM, Terlecky SR, Dice JF, Knecht E. Selective binding and uptake of ribonuclease A and glyceraldehyde-3-phosphate dehydrogenase by isolated rat liver lysosomes. J Biol Chem 1994; 269: 26374-26380.
33. Cuervo AM. Autophagy: In sickness and in health. Trends Cell Biol 2004; 14: 70-77.
34. Bandyopadhyay U, Kaushik S, Varticovski L, Cuervo AM. The chaperone-mediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane. Mol Cell Biol 2008; 28: 5747-5763.
35. Singh P, Salih M, Leddy JJ, Tuana BS. The muscle-specific calmodulin-dependent protein kinase assembles with the glycolytic enzyme complex at the sarcoplasmic reticulum and modulates the activity of glyceraldehyde-3-phosphate dehydrogenase in a Ca2+/calmodulin-dependent manner. J Biol Chem 2004; 279: 35176-35182.
36. Tisdale EJ. Glyceraldehyde-3-phosphate dehydrogenase is phosphorylated by protein kinase Ciota/lambda and plays a role in microtubule dynamics in the early secretory pathway. J Biol Chem 2002; 277: 3334-3341.
37. Tisdale EJ, Artalejo CR. Src-dependent aprotein kinase C iota/lambda (aPKCiota/lambda) tyrosine phosphorylation is required for aPKCiota/ lambda association with Rab2 and glyceraldehyde-3-phosphate dehydrogenase on pre-golgi intermediates. J Biol Chem 2006; 281 8436-8442.
38. Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005; 7 665-674.
39. Mohr S, Stamler JS, Brune B. Posttranslational modification of glyceraldehyde-3-phosphate dehydrogenase by S-nitrosylation and subsequent NADH attachment. J Biol Chem 1996; 271: 4209-4214.
40. Batthyany C, Schopfer FJ, Baker PR, Duran R, Baker LM, Huang Y et al Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J Biol Chem 2006; 281: 20450-20463.
41. Mohr S, Hallak H, de Boitte A, Lapetina EG, Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1999; 274 9427-9430.
42. Little C, O'Brien PJ. Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 1969; 10: 533-538.
43. Souza JM, Radi R. Glyceraldehyde-3-phosphate dehydrogenase inactivation by peroxynitrite. Arch Biochem Biophys 1998; 360: 187-194.
44. Dastoor Z, Dreyer JL. Potential role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase in apoptosis and oxidative stress. J Cell Sci 2001; 114 (Pt 9): 1643-1653.
45. Ishitani R, Kimura M, Sunaga K, Katsube N, Tanaka M, Chuang DM. An antisense oligodeoxynucleotide to glyceraldehyde-3-phosphate dehydrogenase blocks age-induced apoptosis of mature cerebrocortical neurons in culture. J Pharmacol Exp Ther 1996; 278: 447-454.
46. Ishitani R, Sunaga K, Hirano A, Saunders P, Katsube N, Chuang DM. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J Neurochem 1996; 66: 928-935.
47. Ishitani R, Tanaka M, Sunaga K, Katsube N, Chuang DM. Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 1998; 53: 701-707.
48. Saunders PA, Chalecka-Franaszek E, Chuang DM. Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 1997; 69: 1820-1828.
49. Sawa A, Khan AA, Hester LD, Snyder SH. Glyceraldehyde-3-phosphate dehydrogenase: Nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci USA 1997; 94: 11669-11674.
50. Schmitz HD. Reversible nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase upon serum depletion. Eur J Cell Biol 2001; 80: 419-427.
51. Brown VM, Krynetski EY, Krynetskaia NF, Grieger D, Mukatira ST, Murti KG et al. A novel CRM1-mediated nuclear export signal governs nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase following genotoxic stress. J Biol Chem 2004; 279: 5984-5992.
52. Park J, Han D, Kim K, Kang Y, Kim Y. O-GlcNAcylation disrupts glyceraldehyde-3-phosphate dehydrogenase homo-tetramer formation and mediates its nuclear translocation. Biochim Biophys Acta 2009; 1794: 254-262.
53. Ishitani R, Chuang DM. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci USA 1996; 93: 9937-9941.
54. Maruyama W, Akao Y, Youdim MB, Davis BA, Naoi M. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem 2001; 78: 727-735.
55. Saunders PA, Chen RW, Chuang DM. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis. J Neurochem 1999; 72: 925-932.
56. Nakajima H, Amano W, Fujita A, Fukuhara A, Azuma YT, Hata F et al. The active site cysteine of the proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase is essential in oxidative stress-induced aggregation and cell death. J Biol Chem 2007; 282: 26562-26574.
57. Coan C, Ji JY, Hideg K, Mehlhorn RJ. Protein sulfhydryls are protected from irreversible oxidation by conversion to mixed disulfides. Arch Biochem Biophys 1992; 295: 369-378.
58. Cotgreave IA, Gerdes R, Schuppe-Koistinen I, Lind C. S-glutathionylation of glyceraldehyde-3-phosphate dehydrogenase: Role of thiol oxidation and catalysis by glutaredoxin. Methods Enzymol 2002; 348: 175-182.
59. Ralser M, Wamelink MM, Kowald A, Gerisch B, Heeren G, Struys EA et al Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol 2007; 6: 10.
60. Morigasaki S, Shimada K, Ikner A, Yanagida M, Shiozaki K. Glycolytic enzyme GAPDH promotes peroxide stress signaling through multistep phosphorelay to a MAPK cascade. Mol Cell 2008; 30: 108-113.
61. Hara MR, Cascio MB, Sawa A. GAPDH as a sensor of NO stress. Biochim Biophys Acta 2006; 1762: 502-509.
62. Hara MR, Snyder SH. Nitric oxide-GAPDH-Siah: A novel cell death cascade. Cell Mol Neurobiol 2006; 26: 527-538.
63. Sen N, Hara MR, Kornberg MD, Cascio MB, Bae BI, Shahani N et al. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 2008; 10: 866-873.
64. Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Geant A et al. Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter. Proc Natl Acad Sci USA 2004; 101: 3510-3515.
65. Chen RW, Saunders PA, Wei H, Li Z, Seth P, Chuang DM. Involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and p53 in neuronal apoptosis: Evidence that GAPDH is upregulated by p53. J Neurosci 1999; 19: 9654-9662.
66. Du ZX, Wang HQ, Zhang HY, Gao DX. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 2007; 148: 4352-4361.
67. Tarze A, Deniaud A, Le Bras M, Maillier E, Molle D, Larochette N et al. GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 2007; 26: 2606-2620.
68. Chuang DM, Hough C, Senatorov VV. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 2005; 45: 269-290.
69. Mazzola JL, Sirover MA. Alteration of nuclear glyceraldehyde-3-phosphate dehydrogenase structure in Huntington's disease fibroblasts. Brain Res Mol Brain Res 2002; 100: 95-101.
70. Shiozawa M, Fukutani Y, Arai N, Cairns NJ, Mizutani T, Isaki K et al Glyceraldehyde 3-phosphate dehydrogenase and endothelin-1 immunoreactivity is associated with cerebral white matter damage in dentatorubral-pallidoluysian atrophy. Neuropathology 2003; 23 36-43.
71. Tatton NA. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp Neurol 2000; 166: 29-43.
72. Mazzola JL, Sirover MA. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer's disease fibroblasts. J Neurosci Res 2003; 71: 279-285.
73. Tsuchiya K, Tajima H, Yamada M, Takahashi H, Kuwae T, Sunaga K et al Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: Anti-dementia drugs depress its activation in apoptosis. Life Sci 2004; 74: 3245-3258.
74. Bae BI, Hara MR, Cascio MB, Wellington CL, Hayden MR, Ross CA et al Mutant huntingtin: Nuclear translocation and cytotoxicity mediated by GAPDH. Proc Natl Acad Sci USA 2006; 103: 3405-3409.
75. Verdier Y, Foldi I, Sergeant N, Fulop L, Penke Z, Janaky T et al. Characterization of the interaction between Abeta 1-42 and glyceraldehyde phosphodehydrogenase. J Pept Sci 2008; 14: 755-762.
76. Cumming RC, Schubert D. Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. Faseb J 2005; 19 2060-2062.
77. Hara MR, Thomas B, Cascio MB, Bae BI, Hester LD, Dawson VL et al. Neuroprotection by pharmacologic blockade of the GAPDH death cascade. Proc Natl Acad Sci USA 2006; 103: 3887-3889.
78. Miller R, Bradley W, Cudkowicz M, Hubble J, Meininger V, Mitsumoto H et al. Phase II/III randomized trial of TCH346 in patients with ALS. Neurology 2007; 69: 776-784.
79. Altenberg B, Greulich KO. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004; 84: 1014-1020.
80. Epner DE, Coffey DS. There are multiple forms of glyceraldehyde-3-phosphate dehydrogenase in prostate cancer cells and normal prostate tissue. Prostate 1996; 28: 372-378.
81. Lavallard VJ, Pradelli LA, Paul A, Beneteau M, Jacquel A, Auberger P et al. Modulation of caspase-independent cell death leads to resensitization of imatinib mesylate-resistant cells. Cancer Res 2009; 69: 3013-3020.
82. Lu H, Zhang Y, Roberts DD, Osborne CK, Templeton NS. Enhanced gene expression in breast cancer cells in vitro and tumors in vivo. Mol Ther 2002; 6: 783-792.
83. Revillion F, Pawlowski V, Hornez L, Peyrat JP. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer 2000; 36: 1038-1042.
84. Detterbeck FC, Vansteenkiste JF, Morris DE, Dooms CA, Khandani AH, Socinski MA. Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer. Chest 2004; 126: 1656-1666.
85. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991; 32: 623-648; discussion 649-650.
86. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 2009; 324: 1029-1033.
87. Colell A, Ricci JE, Tait S, Milasta S, Maurer U, Bouchier-Hayes L et al. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 2007; 129 983-997.
88. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 2005; 6 268-275.
89. Tait SW, Green DR. Caspase-independent cell death: Leaving the set without the final cut. Oncogene 2008; 27: 6452-6461.
90. Liu JR, Opipari AW, Tan L, Jiang Y, Zhang Y, Tang H et al. Dysfunctional apoptosome activation in ovarian cancer: Implications for chemoresistance. Cancer Res 2002; 62: 924-931.
91. Schimmer AD, Dalili S, Batey RA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ 2006; 13: 179-188.
92. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001; 409: 207-211.
93. Bertin S, Samson M, Pons C, Guigonis JM, Gavelli A, Baque P et al. Comparative proteomics study reveals that bacterial CpG motifs induce tumor cell autophagy in vitro and in vivo. Mol Cell Proteomics 2008; 12: 2311-2322.
94. Lee MN, Ha SH, Kim J, Koh A, Lee CS, Kim JH et al. Glycolytic flux signals to mTOR through glyceraldehyde-3-phosphate dehydrogenase-mediated regulation of Rheb. Mol Cell Biol 2009; 29: 3991-4001.
95. Hulleman E, Kazemier KM, Holleman A, VanderWeele DJ, Rudin CM, Broekhuis MJ et al. Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood 2009; 113: 2014-2021.
96. Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: A poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 1997; 3: 999-1007.
97. Azam S, Jouvet N, Jilani A, Vongsamphanh R, Yang X, Yang S et al. Human glyceraldehyde-3-phosphate dehydrogenase plays a direct role in reactivating oxidized forms of the DNA repair enzyme APE1. J Biol Chem 2008; 283: 30632-30641.
98. Carujo S, Estanyol JM, Ejarque A, Agell N, Bachs O, Pujol MJ. Glyceraldehyde 3-phosphate dehydrogenase is a SET-binding protein and regulates cyclin B-cdk1 activity. Oncogene 2006; 25: 4033-4042.
99. Pelicano H, Martin DS, Xu RH, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 2006; 25: 4633-4646.
100. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B. Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 2008; 17: 1533-1545.
101. Kumagai S, Narasaki R, Hasumi K. Glucose-dependent active ATP depletion by koningic acid kills high-glycolytic cells. Biochem Biophys Res Commun 2008; 365: 362-368.
102. Ishitani R, Sunaga K, Tanaka M, Aishita H, Chuang DM. Overexpression of glyceraldehyde-3-phosphate dehydrogenase is involved in low K+-induced apoptosis but not necrosis of cultured cerebellar granule cells. Mol Pharmacol 1997; 51: 542-550.
103. Fukuhara Y, Takeshima T, Kashiwaya Y, Shimoda K, Ishitani R, Nakashima K. GAPDH knockdown rescues mesencephalic dopaminergic neurons from MPP+ -induced apoptosis. Neuroreport 2001; 12: 2049-2052.
104. Maruyama W, Oya-Ito T, Shamoto-Nagai M, Osawa T, Naoi M. Glyceraldehyde-3-phospate dehydrogenase is translocated into nuclei through Golgi apparatus during apoptosis induced by 6-hydroxydopamine in human dopaminergic SH-SY5Y cells. Neurosci Lett 2002; 321: 29-32.
105. Barbini L, Rodriguez J, Dominguez F, Vega F. Glyceraldehyde-3-phosphate dehydrogenase exerts different biologic activities in apoptotic and proliferating hepatocytes according to its subcellular localization. Mol Cell Biochem 2007; 300: 19-28.